PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aaciBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
 
Allergy Asthma Clin Immunol. 2012; 8(Suppl 1): A7.
Published online Nov 2, 2012. doi:  10.1186/1710-1492-8-S1-A7
PMCID: PMC3487878
Measured depth of subcutaneous tissue on posterolateral arm of aeroallergen immunotherapy patients
Laura Kim,1 Ryan Potts,2 Clark Eeuwes,3 Arunmozhi Dominic,3 Immaculate Nevis,4 and Harold L Kimcorresponding author3,4
1McGill University, Montréal, Québec, Canada
2University of Waterloo, Waterloo, Ontario, Canada
3University of Western Ontario, London, Ontario, Canada
4McMaster University, Hamilton, Ontario, Canada
corresponding authorCorresponding author.
Harold L Kim: hlkimkw/at/gmail.com
Supplement
Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2012
Publication of this supplement was supported by the CSACI.
Conference
Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2012
11-14 October 2012
Calgary, Canada
Background
Subcutaneous immunotherapy (SIT) injections for aeroallergens are often utilized in patients. SIT should be injected into the subcutaneous space in the mid-posterolateral upper arm. If the injections are given intramuscularly (IM), there may be an increased risk of anaphylaxis. In our allergy clinic, SIT is given with BD Safety Glide™ Allergy syringes with needle length 13 mm. There is a risk of the SIT being injected IM if patients have a skin to muscle depth (STMD) less than 13 mm.
Methods
Charts were reviewed in an allergy clinic for patients on SIT where an ultrasound of the left posterolateral arm was done to measure STMD. Baseline characteristics of the two groups of patients with STMD greater than, and less than or equal to 13 mm were compared. The proportions of patients with STMD greater than 4mm, 6 mm, 8 mm, and 10 mm were calculated. Multivariable logistic regression was performed with age, sex, BMI and race.
Results
Ultrasounds had been completed on 186 patients on SIT. There were 149 (80%) with STMD less than 13mm. Baseline characteristics including age, sex and BMI differed among the two groups (p < 0.05). Based on the logistic regression analysis, BMI was significantly associated with STMD. There were 168 (90%) patients with more than 4mm STMD.
Conclusions
With standard allergy syringes, most patients on SIT are at risk of receiving the injections IM. A needle length of 4 mm would significantly decrease the risk of SIT being given IM.
Articles from Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology are provided here courtesy of
BioMed Central